Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

About this update from Waters Corporation

[{"type":"text","content":"First Quarter 2026 Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses.","length":185,"tagName":"p"}]},{"val":[{"type":"text","content":"Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.","length":273,"tagName":"p"}]},{"val":[{"type":"text","content":"The Biosciences and Diagnostic Solutions businesses generated $520 million of reported revenue since the closing of the acquisition – $40 million above guidance – driven by traction from commercial execution and operational improvement initiatives launched during the quarter.","length":276,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP EPS of ($0.87); Adjusted EPS of $2.70 grew 20% year-over-year, driven by better-than-expected revenue and margin performance.","length":130,"tagName":"p"}]},{"val":[{"type":"text","content":"The Company is raising its full year 2026 organic constant currency revenue growth guidance to 6.5% to 8.0% and now expects the acquired businesses to generate $3.035 billion of reported revenue in 2026. The Company is also raising its full-year 2026 adjusted EPS guidance to $14.40 to $14.60, reflecting double-digit adjusted EPS growth.","length":338,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1202,"olType":false},{"type":"text","content":"MILFORD, Mass., May 5, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT), today announced its financial results for the first quarter of 2026, marking the first reporting period that includes financial results for the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company, which was acquired by Waters on February 9, 2026.","length":356,"tagName":"p"},{"type":"text","content":"Overall Financial Results","length":25,"tagName":"p"},{"type":"text","content":"The Company's reported revenue for the first quarter of 2026 was $1.267 billion, reflecting $747 million of organic revenue and $520 million of revenue from Biosciences...

More updates from Waters Corporation